机译:治疗性和Supratherapeutic剂量在健康的中国受试者中的耐受性和药代动力学,以及基于药代动力学/药物学分析的Contezolid给药方案评估
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
Fudan Univ Huashan Hosp Inst Antibiot 12 Wulumiqi Zhong Rd Shanghai 200040 Peoples R China;
contezolid; MRX-I; pharmacokinetic-pharmacodynamic; pharmacokinetics; supra-therapeutic doses; tolerability;
机译:治疗性和Supratherapeutic剂量在健康的中国受试者中的耐受性和药代动力学,以及基于药代动力学/药物学分析的Contezolid给药方案评估
机译:健康成人治疗和Suprathera等剂量曲马多剂量的安全性,耐受性和药代动力学:随机,双盲,安慰剂控制的多个上升剂量研究
机译:健康成人治疗和Suprathera等剂量曲马多剂量的安全性,耐受性和药代动力学:随机,双盲,安慰剂控制的多个上升剂量研究
机译:健康日本和白种人志愿者舌下芬太尼的药代动力学和耐受性:I期,开放标签单剂量研究
机译:使用群体药代动力学/药效学方法,与非肥胖患者相比,肥胖患者的β-内酰胺抗菌药物剂量优化。
机译:基于药代动力学/药效学分析的左半唑代唑片剂的药代动力学及提出给药方案
机译:健康中国科目中单剂量双剂量的药代动力学,药效动物,耐受性和安全性